Skip to main content
Nataniel Lester-Coll, MD, Radiation Oncology, Burlington, VT

NatanielHernanLester-CollMD

Radiation Oncology Burlington, VT

Urologic Cancer

Chair, Department of Radiation Oncology, University of Vermont Health Network

Dr. Lester-Coll is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lester-Coll's full profile

Already have an account?

  • Office

    111 Colchester Ave
    Burlington, VT 05401
    Phone+1 802-847-3506

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Radiation Oncology, 2013 - 2017
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Internal Medicine, 2012 - 2013
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2012, MD
  • Brown University
    Brown UniversityBS, Neurosciece, Honors, 2002 - 2006

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2020 - 2026
  • VT State Medical License
    VT State Medical License 2017 - 2026
  • CT State Medical License
    CT State Medical License 2014 - 2017
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Chief Resident, Radiation Oncology Yale-New Haven Hospital
  • Best of ASTRO Abstract Recognition American Society for Radiation Oncology, 2016
  • Red Journal’s Outstanding Reviewer Award for 2016 ASTRO, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Cost-Effectiveness of Prostate Radiation Therapy for Men with Newly Diagnosed Low-Burden Metastatic Prostate Cancer  
    Nataniel H Lester-Coll, Steven Ades, James B Yu, JAMA Network Open
  • The role of stereotactic body radiation therapy in the management of oligometastatic lung cancer  
    Lester-Coll NH, Decker RH, Lung Cancer Management, 7/1/2015

Press Mentions

  • Cardiac Risk of Prostate Cancer Patients Should Factor in Use of Hormone Therapy, Study Says
    Cardiac Risk of Prostate Cancer Patients Should Factor in Use of Hormone Therapy, Study SaysOctober 10th, 2016
  • Mibefradil Dihydrochoride with Hypofractionated Radiation for Recurrent Glioblastoma
    Mibefradil Dihydrochoride with Hypofractionated Radiation for Recurrent GlioblastomaSeptember 30th, 2016
  • SBRT Safe, Effective for Intermediate-Risk Prostate Cancer
    SBRT Safe, Effective for Intermediate-Risk Prostate CancerOctober 17th, 2023

Professional Memberships

Other Languages

  • Spanish